Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics

Interview With Rising Leader Hanadie Yousef

CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.

Juvena Therapeutics Mines Human Cell-Secreted Proteins For Potential Therapeutics • Source: Shutterstock

Rising Leaders Home

Based in Redwood City, CA, Juvena Therapeutics employs advanced computing to map the 4,000 proteins secreted by human cells. Through an AI-enabled platform, the company can identify potential protein-disease relationships and engineer medicines accordingly

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rising Leaders

More from Leadership